Senna (sennosides recalls

The FDA has published 4 recalls involving Senna (sennosides since 2016. The latest was reported on 26 Jan 2022. Most were for potency & assay. Geritrex has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2016

Last 12 months0reported

Class I125% of total

Ongoing0latest 26 Jan 2022

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 1 25%Class II 3 75%Class III 0 0%

Why senna (sennosides is recalled

Companies

By year

2022125%
2019250%
2016125%

All senna (sennosides recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
26 Jan 2022Drug	CLASS I	Senna Syrup (sennosides) 8.8 mg/ unit-dose cups recalled by Lohxa	Lohxa	Sterility	Nationwide
19 Jun 2019Drug	CLASS II	Senna (sennosides 8.8 mg) Syrup recalled by Geritrex	Geritrex	Potency & Assay	Nationwide
19 Jun 2019Drug	CLASS II	Senna (sennosides 8.8 mg) Syrup recalled by Geritrex	Geritrex	Potency & Assay	Nationwide
5 Oct 2016Drug	CLASS II	Senna Syrup (sennosides) 8.8 mg recalled by Pharmatech	Pharmatech	Manufacturing (CGMP) Deviations	Nationwide

Should you stop taking Senna (sennosides?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.